Cardiology News and Highlights - October 2026

 

Clinical Achievements

Clinical Achievements JOURNEY procedure

UCSF performed its first JOURNEY J-Valve procedure. Sammy Elmariah, MD, MPH, Yousif Ahmad, MD, Neal Shah, MD, and Structural Interventional Fellow Mohammad Thawabi, MD, completed the minimally invasive treatment for severe aortic valve leakage. The patient was discharged following the procedure and is doing well.

​Retirement and Departure

Ian Harris, MD, is retiring after 19 years as UCSF faculty and will return as recall faculty. Dr. Harris joined the UCSF faculty in 2007 and served for 10 years as director of the Adult Congenital Heart Disease Program. Under his leadership, the program experienced substantial growth, expanded its regional outreach, and became one of the five largest ACHD programs in the country. He was inducted into the UCSF Gold-Headed Cane Society as an honored faculty member in 2026.

Alexis Beatty, MD, MAS, left UCSF on October 2 as she prepares to relocate with her family. During her time at UCSF, Dr. Beatty served as Co-Director of the UCSF Cardiac Rehabilitation and Wellness Center and as Faculty Lead of the Training in Clinical Research program. Her research has helped advance new models of cardiac rehabilitation designed to improve participation and access to care.

Awards and Honors

Leila Beach, MD received the Excellence in Interprofessional Teaching Award from the Academy of Medical Educators.

Ed Gerstenfeld, MD, was selected by the Heart Rhythm Society as the recipient of the 2027 Eric N. Prystowsky Lectureship Award, recognizing contributions to the advancement of cardiac electrophysiology. He will deliver the lectureship at Heart Rhythm 2027.

Anna Morrison, RN, Electrophysiology Clinic Nurse, received the September Ambulatory Patient Safety Award for her attention to medication safety. After identifying a potentially fatal interaction between an antibiotic dispensed to a patient and the patient’s cardiac medication, Morrison intervened, contacted the prescribing team, and followed up with the pharmacy to help ensure a safe alternative.

Arun Padmanabhan, MD, PhD, received the Genentech-ASCI Early-Career Impact Award from the American Society for Clinical Investigation.

Appointments and Leadership

Eveline Stock, MD, was appointed Director of the Advanced Lipid and Lifestyle Program. Dr. Stock brings nearly two decades of experience in lipid care and research to the role.

Ed Gerstenfeld, MD, also chaired a Heart Rhythm Society working group developing the “HRS Scientific Statement on Cessation of Oral Anticoagulation after Catheter Ablation of AF.”

Research Highlights

Greg Marcus, MD, MAS, and the OMRON-AF clinical trial are examining whether AI-enabled technology can help detect and confirm atrial fibrillation faster than conventional heart monitoring. The research explores how AI may support earlier recognition of atrial fibrillation and help guide diagnosis and care.

Julio Lamprea-Montealegre, MD, PhD, mentored UCSF medical student Ivan Villasenor on research evaluating Treat CKD, an electronic health record-integrated clinical decision support tool for risk-based chronic kidney disease care. The study found that Treat CKD accurately automated CKD identification and risk classification, calculated kidney and cardiovascular risk, and provided guideline-concordant treatment recommendations.

Mandar Aras, MD, PhD, received an award from Rocket Pharmaceuticals, Inc. for a Phase 1 study evaluating RP-A701 in participants with BAG3 variant-mediated dilated cardiomyopathy.

Alan Baik, MD, received an award from Kiniksa Pharmaceuticals Corporation for a Phase 2 study evaluating the efficacy and safety of KPL-387 monotherapy in participants with well-controlled recurrent pericarditis.

Leila Mohammadi, MD, PhD, received an NIH R21 grant from the National Institute on Drug Abuse for the project “Exploring the Impact of Concurrent Cannabis and Stimulant Medication Use on Cardiovascular Risk.”

Ivan Kuznetsov, MD, is first author of a new study in Nature Cardiovascular Research mapping how cell types and molecular processes change as the right side of the heart progresses from adapting to increased pressure to heart failure. The findings identify widespread changes involving blood vessel, immune, and energy-producing pathways and may offer clues for treatments targeting right ventricular failure.

Xiaoyin Wang, MD, PhD, had a recently published article in the American Journal of Physiology-Heart and Circulatory Physiology selected for APSselect, a collection from the American Physiological Society highlighting notable recently published research in physiology.

In the News

Sanket Dhruva, MD, MHS, was quoted in The Washington Post in an article examining FDA-required postmarket studies of drugs and medical devices and whether those studies are completed as required.

Jorge Kizer, MD, MSc, discussed cardiovascular health among Hispanic adults in a recent AARP report highlighting cardiovascular disease as the leading cause of death in this population in the United States.

Presentations and Professional Contributions

Michelle Albert, MD, MPH, presented Cardiovascular Grand Rounds at the Mayo Clinic in Rochester, Minnesota. She also delivered the DeStevens Lectureship for Medicine Grand Rounds and served as a visiting professor at Northwestern Medicine in Chicago.

Ayesha Salahuddin, MD, presented her cardiac rehabilitation research at the Adult Congenital Heart Association Research Symposium on October 14. The symposium brought together members of the adult congenital heart disease community to share research focused on advancing care and patient-centered outcomes.

Michelle Albert, MD, MPH, and Rita Redberg, MD, MSc, were invited speakers and delivered keynote addresses at the 5th Annual Women’s Cardiovascular Symposium in Cincinnati, Ohio.

Community and Events

NorCal ACHD Cohort photo

NorCal ACHD Collaborative: UCSF launched the NorCal ACHD Collaborative, bringing together adult congenital heart disease teams from UCSF, Stanford, Kaiser Permanente, UC Davis, Sutter Health, and other Northern California centers to strengthen regional collaboration and improve ACHD care. The collaborative will continue quarterly meetings focused on gaps in care, patient initiatives, research collaboration, and regional case conferences.

Updates in Sonoma Photo Collage

Hearts in Sonoma: The UCSF Update on Heart Failure Therapies returned to Sonoma for its fourth year on September 25-26, bringing together 132 paid participants from UCSF, across California, and beyond. Attendance increased 20% over 2025, with more than 30 exhibitors. Martha Gulati, MD, MS, delivered the keynote address, “Addressing Heart Failure in Women.”